Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$6.6M
Net $3.5M sold
Sales
$3.5M
2 transactions
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Tessari Eben
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Sep 8, 2025
- Transaction Date
- Sep 4, 2025
- Accession Number
- 0001415889-25-023878
- Form Type
- 4
- Net Trading Amount
- -$3.5M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 4, 2025 | Class A Ordinary Share | 38,725 | $15.50 | Exercise | $600.2K |
| Sep 4, 2025 | Class A Ordinary Share | 46,546 | $15.52 | Exercise | $722.4K |
| Sep 4, 2025 | Class A Ordinary Share | 85,271 | $35.52 | Sale | $3.0M |
| Sep 5, 2025 | Class A Ordinary Share | 13,389 | $15.52 | Exercise | $207.8K |
| Sep 5, 2025 | Class A Ordinary Share | 13,389 | $35.66 | Sale | $477.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Sep 4, 2025 | Derivative | 38,725 | $15.50 | Exercise | $600.2K |
| Sep 4, 2025 | Derivative | 46,546 | $15.52 | Exercise | $722.4K |
| Sep 5, 2025 | Derivative | 13,389 | $15.52 | Exercise | $207.8K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $35.50 and $35.545. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $35.52 and $35.84. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F4)The option is fully vested and exercisable.